The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
Cases of COVID-19 have waned in the weeks since the launch of the latest booster shot and the beginning of the academic school year. But, once again, COVID-19 isn’t the only respiratory infection ...